BROOKS Intraday Analysis...

BROOKS Share Price

Open 136.80 Change Price %
High 137.50 1 Day -1.55 -1.14
Low 134.30 1 Week -3.50 -2.53
Close 134.85 1 Month -5.95 -4.23
Volume 29045 1 Year 43.70 47.94
52 Week High 194.70
52 Week Low 65.40
BROOKS Important Levels
Resistance 2 137.82
Resistance 1 136.59
Pivot 135.55
Support 1 133.11
Support 2 131.88
NSE INDIA Most Active Stocks
SUZLON 18.35 -2.91%
JPASSOCIAT 13.05 -2.61%
BANKBARODA 172.30 1.92%
IDEA 87.60 -3.63%
SINTEX 104.25 4.41%
HINDALCO 188.70 -3.18%
PNB 147.25 4.06%
STAMPEDE 21.65 6.39%
SBIN 279.45 1.07%
RCOM 38.15 -1.29%
More..
NSE INDIA Top Gainers Stocks
FARMAXIND 0.10 100.00%
VKSPL 0.10 100.00%
KSERASERA 0.20 33.33%
ATNINTER 0.30 20.00%
KANANIIND 15.90 20.00%
ONELIFECAP 26.80 19.91%
KAUSHALYA 5.50 19.57%
LINCPEN 308.65 17.72%
BPL 73.35 15.24%
BPL 73.35 15.24%
More..
NSE INDIA Top Losers Stocks
PTL 56.45 -62.81%
PTL 56.45 -62.81%
RASOYPR 0.15 -25.00%
RAJRAYON 0.25 -16.67%
XLENERGY 2.55 -15.00%
BLUECHIP 0.30 -14.29%
INFIBEAM 1218.95 -11.63%
REISIXTEN 0.40 -11.11%
IOLCP 78.55 -11.09%
REFEX 20.90 -9.91%
More..

Brooks Laboratories Limited (NSE: BROOKS)

BROOKS Technical Analysis 2
As on 27th Mar 2017 BROOKS Share Price closed @ 134.85 and we RECOMMEND Buy for LONG-TERM with Stoploss of 120.69 & Strong Sell for SHORT-TERM with Stoploss of 142.06 we also expect STOCK to react on Following IMPORTANT LEVELS.
BROOKS Target for March
1st Target up-side 156.12
2nd Target up-side 166.72
3rd Target up-side 177.32
1st Target down-side 125.88
2nd Target down-side 115.28
3rd Target down-side 104.68
BROOKS Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 37.97 Sideways
MFI (14) MFI is 57.84 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is 10.51 Range Bound
PSAR Stoploss For Short Sell 150.26
10 Day Avg Volume Traded -42.49 % Less then 10 Day Average Volume
BROOKS Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
BROOKS Address
BROOKS
N/A
BROOKS Latest News
Stocks to Watch: NXP Semi, Hewlett-Packard, Johnson & Johnson   Wall Street Journal (blog)   - 02nd Mar 15
Brooks Labs standalone Dec '14 sales at Rs 23.68 crore   Moneycontrol.com   - 17th Feb 15
Tesco recalls fruit drinks over 'foreign bodies' and 'unusual smell'   Daily Mail   - 28th Jan 15
Sebi slaps Rs 11.80 cr penalty on Brooks Labs and 5 executives   Business Standard   - 12th Jan 15
Brooks Laboratories Ltd clarifies on SEBI order against the firm   Equity Bulls   - 05th Dec 14
Clarification sought from Brooks Laboratories Ltd   Hindu Business Line   - 03rd Dec 14
Sebi passes orders against 8 companies for non-disclosures in IPO   Economic Times   - 02nd Dec 14
Brooks Laboratories appoints SGCO & Co as statutory auditors   Moneycontrol.com   - 12th Aug 14
SEBI imposes Rs. 53.5 cr fine in Brooks Lab IPO case   Hindu Business Line   - 31st Dec 13
IPO Crackdown-2: Brooks Laboratories   Moneylife Personal Finance site and magazine   - 13th Jan 12
Interactive Technical Analysis Chart Brooks Laboratories Limited ( BROOKS NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Brooks Laboratories Limited
BROOKS Business Profile
Brooks Labs is in the Pharmaceuticals sector. Brooks Laboratories Ltd. was established in 2002 and maintains its strong presence in the Pharmaceutical industry as a Contract Manufacturing Company since its inception. Brooks Laboratories Ltd is a Research and Development driven Pharmaceutical manufacturing company, in last 6 years company has successfully established itself as a reputed Contract Manufacturing company for latest molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups. The current market capitalisation stands at Rs 28.65 crore.The company has reported a standalone sales of Rs 25.20 crore and a Net Profit of Rs 1.9 crore for the quarter ended Sep 2013. The company management includes Atul Ranchal - Chairman, Rajesh Mahajan - Managing Director, D S Maity - Director & CEO, Rajnish Bedi - Independent Director, Bhaskar Sharma - Additional Director. It is listed on the BSE with a BSE Code of 533543 and the NSE with an NSE Code of BROOKS. Its Registered office is at Village Kishanpura, Nalagarh Road,,Baddi Solan District,Himachal Pradesh - 174101.